Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.525
-0.305 (-7.96%)
At close: Jun 5, 2025, 4:00 PM
3.550
+0.025 (0.70%)
After-hours: Jun 5, 2025, 7:33 PM EDT
Achieve Life Sciences Market Cap
Achieve Life Sciences has a market cap or net worth of $122.26 million as of June 5, 2025. Its market cap has decreased by -28.79% in one year.
Market Cap
122.26M
Enterprise Value
111.58M
1-Year Change
-28.79%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since December 1, 1998, Achieve Life Sciences's market cap has increased from $67.40M to $122.26M, an increase of 81.40%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 132.80M | 9.66% |
| Dec 31, 2024 | 121.10M | 38.88% |
| Dec 29, 2023 | 87.20M | 266.39% |
| Dec 30, 2022 | 23.80M | -67.62% |
| Dec 31, 2021 | 73.50M | 150.85% |
| Dec 31, 2020 | 29.30M | 565.91% |
| Dec 31, 2019 | 4.40M | -45.68% |
| Dec 31, 2018 | 8.10M | -49.38% |
| Dec 29, 2017 | 16.00M | 6.67% |
| Dec 30, 2016 | 15.00M | -58.45% |
| Dec 31, 2015 | 36.10M | -25.87% |
| Dec 31, 2014 | 48.70M | -60.31% |
| Dec 31, 2013 | 122.70M | -36.19% |
| Dec 31, 2012 | 192.30M | 68.09% |
| Dec 30, 2011 | 114.40M | -29.47% |
| Dec 31, 2010 | 162.20M | 20.59% |
| Dec 31, 2009 | 134.50M | 715.15% |
| Dec 31, 2008 | 16.50M | 1.23% |
| Dec 31, 2007 | 16.30M | -92.75% |
| Dec 29, 2006 | 224.80M | 47.89% |
| Dec 30, 2005 | 152.00M | 101.86% |
| Dec 31, 2004 | 75.30M | -17.34% |
| Dec 31, 2003 | 91.10M | 214.14% |
| Dec 31, 2002 | 29.00M | -68.75% |
| Dec 31, 2001 | 92.80M | 1,500.00% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.23B |
| Johnson & Johnson | 372.72B |
| AbbVie | 332.86B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 274.28B |
| Abbott Laboratories | 232.23B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |